A Phase 1 Study of XL019 in Adults With Polycythemia Vera

Dose-Escalation Study of SCD-101 in Sickle Cell Disease

NCT02380079 ·Status: UNKNOWN ·Phase: PHASE1

A Study to Evaluate GBT021601-012 Single Dose and Multiple Dose in Participants With Sickle Cell Disease (SCD)

NCT04983264 ·Status: COMPLETED ·Phase: PHASE1

Oxbryta® Product Registry An Observational Study Designed to Evaluate the Effect of Oxbryta in Individuals With SCD

NCT04930445 ·Status: TERMINATED

A Study to Evaluate Safety, Pharmacokinetic, and Biological Activity of INCB059872 in Subjects With Sickle Cell Disease

NCT03132324 ·Status: TERMINATED ·Phase: PHASE1

Evaluation of Efficacy and Safety of a Single Dose of Exa-cel in Participants With Severe Sickle Cell Disease, βS/ βC Genotype

NCT05951205 ·Status: WITHDRAWN ·Phase: PHASE3

Prospective Observational Study Of Patients With Polycythemia Vera In US Clinical Practices (REVEAL)

NCT02252159 ·Status: COMPLETED

A Prospective, Non-interventional Study of JAKAVI® (Ruxolitinib) Treatment in Patients With Polycythemia Vera

NCT05853445 ·Status: COMPLETED

YOLT-204 in Patients With Hemoglobinopathies

NCT07190001 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1

Study of BEBT-507 Injection in Subjects With Polycythemia Vera (PV)

NCT07012109 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

Safety, Pharmacokinetic, and Pharmacodynamic Study of NKTT120 in Adult Patients With Stable Sickle Cell Disease (SCD)

NCT01783691 ·Status: COMPLETED ·Phase: PHASE1

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Oral GSK4172239D Compared With Placebo in Sickle Cell Disease Participants Aged 18 to 50 Years

NCT05660265 ·Status: TERMINATED ·Phase: PHASE1

Safety of Blood Stem Cell Mobilization With Plerixafor in Patients With Sickle Cell Disease

NCT03664830 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Study of Intravenous GMI-1070 in Adults With Sickle Cell Disease

NCT00911495 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study of the Efficacy of MK-0683 in Patients With Polycythaemia Vera and Essential Thrombocythaemia

NCT00866762 ·Status: UNKNOWN ·Phase: PHASE2

Retrospective Real World Oxbryta® Data Collection and Analysis Study

NCT04930328 ·Status: COMPLETED

A GBT021601 ADME Microtracer Study in Healthy Volunteers

NCT05718687 ·Status: COMPLETED ·Phase: PHASE1

Safety Study of Pegylated Interferon Alpha 2b to Treat Polycythemia Vera

NCT01193699 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Safety of Single Doses of CSL889 in Adult Patients With Sickle Cell Disease

NCT04285827 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety of M281 in Adults With Warm Autoimmune Hemolytic Anemia

NCT04119050 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3

Assessment of Tolerance of Mobilizing Peripheral Hematopoietic Stem Cells by Plerixafor in Sickle Cell Patients

NCT02212535 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Pharmacokinetics, Pharmacodynamics and Safety of Epeleuton in Patients With Sickle Cell Disease

NCT05861453 ·Status: COMPLETED ·Phase: PHASE2

Early-goal Directed Automated Red Blood Cell Exchange for Acute Chest Syndrome in Sickle Cell Disease

NCT06214845 ·Status: NOT_YET_RECRUITING ·Phase: NA

A Dose-Finding Study of Tebapivat to Assess Efficacy, and Safety in Participants With Sickle Cell Disease (SCD)

NCT06924970 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Hemolysis Related Complications in SCD. A Phase II Study With Voxelotor

NCT05199766 ·Status: UNKNOWN ·Phase: PHASE2

AB1 in Adult Patients with Sickle Cell Disease (SCD)

NCT05261711 ·Status: TERMINATED ·Phase: PHASE1/PHASE2